Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 423

1.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
2.

Medical abortions performed by specialists in private practice.

Pay ASD, Aabø RS, Økland I, Janbu T, Iversen OE, Løkeland M.

Tidsskr Nor Laegeforen. 2018 May 28;138(9). doi: 10.4045/tidsskr.18.0041. Print 2018 May 29. Norwegian, English.

3.

Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears.

Vintermyr OK, Andersland MS, Bjørge T, Skar R, Iversen OE, Nygård M, Haugland HK.

Int J Cancer. 2018 Aug 15;143(4):851-860. doi: 10.1002/ijc.31390. Epub 2018 Apr 6.

PMID:
29569718
4.

Østrogener i menopausen – på tide å endre anbefalingene?

Eriksen EF, Moen MH, Iversen OE.

Tidsskr Nor Laegeforen. 2018 Mar 19;138(6). doi: 10.4045/tidsskr.17.1059. Print 2018 Mar 20. Norwegian. No abstract available.

PMID:
29557135
Free Article
5.

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.

Moreira ED, Giuliano AR, de Hoon J, Iversen OE, Joura EA, Restrepo J, Van Damme P, Vandermeulen C, Ellison MC, Krick A, Shields C, Heiles B, Luxembourg A.

Hum Vaccin Immunother. 2018 Feb 1;14(2):396-403. doi: 10.1080/21645515.2017.1403700. Epub 2017 Dec 14.

6.

4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years.

Ferris DG, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Mehlsen J, Chatterjee A, Iversen OE, Joshi A, Chu JL, Krick AL, Saah A, Das R.

Pediatrics. 2017 Dec;140(6). pii: e20163947. doi: 10.1542/peds.2016-3947.

PMID:
29167376
7.

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.

Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, Muñoz N, Myers E, Paavonen J, Pitisuttihum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Papillomavirus Res. 2016 Dec;2:61-69. doi: 10.1016/j.pvr.2016.03.002. Epub 2016 Mar 14.

8.

Does the editorial committee still have a role to play?

Dale O, Berntsen EM, Brekke M, Høye A, Iversen OE, Næss AB, Wisborg T.

Tidsskr Nor Laegeforen. 2017 Sep 18;137(17). doi: 10.4045/tidsskr.17.0342. Print 2017 Sep 19. Norwegian, English. No abstract available.

9.

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A.

Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5.

PMID:
28886907
10.

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.

Petersen LK, Restrepo J, Moreira ED Jr, Iversen OE, Pitisuttithum P, Van Damme P, Joura EA, Olsson SE, Ferris D, Block S, Giuliano AR, Bosch X, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Hyatt D, Maansson R, Moeller E, Qi H, Roberts C, Luxembourg A.

Papillomavirus Res. 2017 Jun;3:105-115. doi: 10.1016/j.pvr.2017.03.002. Epub 2017 Mar 16.

11.

[The HPV vaccine ten years - what's the status?].

Iversen OE.

Tidsskr Nor Laegeforen. 2017 Mar 21;137(6):430-431. doi: 10.4045/tidsskr.17.0086. eCollection 2017 Mar. Norwegian. No abstract available.

12.

Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.

Johansen N, Liavaag AH, Iversen OE, Dørum A, Braaten T, Michelsen TM.

Acta Obstet Gynecol Scand. 2017 May;96(5):547-555. doi: 10.1111/aogs.13120. Epub 2017 Mar 27.

PMID:
28236297
13.

Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.

Løkeland M, Bjørge T, Iversen OE, Akerkar R, Bjørge L.

Int J Epidemiol. 2017 Apr 1;46(2):643-651. doi: 10.1093/ije/dyw270.

14.

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.

Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, Dvorak V, Kim KH, Cestero RM, Berkovitch M, Ceyhan M, Ellison MC, Ritter MA, Yuan SS, DiNubile MJ, Saah AJ, Luxembourg A.

JAMA. 2016 Dec 13;316(22):2411-2421. doi: 10.1001/jama.2016.17615.

PMID:
27893068
15.

Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases.

Iversen OJ, Lysvand H, Slupphaug G.

Clin Immunol. 2017 Jan;174:10-17. doi: 10.1016/j.clim.2016.11.006. Epub 2016 Nov 15. Review.

16.

A single Legionella pneumophila genotype in the freshwater system in a ship experiencing three separate outbreaks of legionellosis in 6 years.

Ahlen C, Aas M, Krusnell J, Iversen OJ.

Microb Ecol Health Dis. 2016 Aug 10;27:31148. doi: 10.3402/mehd.v27.31148. eCollection 2016.

17.

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.

Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A.

Pediatrics. 2016 Aug;138(2). pii: e20154387. doi: 10.1542/peds.2015-4387. Epub 2016 Jul 15.

18.

In pursuit of rigour and accountability in participatory design.

Frauenberger C, Good J, Fitzpatrick G, Iversen OS.

Int J Hum Comput Stud. 2015 Feb;74:93-106.

19.

Psoriasis pathogenesis - Pso p27 constitutes a compact structure forming large aggregates.

Lysvand H, Helland R, Hagen L, Slupphaug G, Iversen OJ.

Biochem Biophys Rep. 2015 Jun 9;2:132-136. doi: 10.1016/j.bbrep.2015.06.001. eCollection 2015 Jul.

20.

Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine.

Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J.

Hum Vaccin Immunother. 2015;11(6):1313-22. doi: 10.1080/21645515.2015.1012010.

21.

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.

N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.

22.

Topical hexaminolevulinate photodynamic therapy for the treatment of persistent human papilloma virus infections and cervical intraepithelial neoplasia.

Hillemanns P, Einstein MH, Iversen OE.

Expert Opin Investig Drugs. 2015 Feb;24(2):273-81. doi: 10.1517/13543784.2015.990150. Epub 2014 Dec 16. Review.

PMID:
25514095
23.

A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.

Hillemanns P, Garcia F, Petry KU, Dvorak V, Sadovsky O, Iversen OE, Einstein MH.

Am J Obstet Gynecol. 2015 Apr;212(4):465.e1-7. doi: 10.1016/j.ajog.2014.10.1107. Epub 2014 Oct 31.

PMID:
25467012
24.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, Steben M, Wheeler CM, Perez G, Saah A, Luxembourg A, Sings HL, Velicer C.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008. doi: 10.1158/1055-9965.EPI-14-0410.

25.

Long-term study of a quadrivalent human papillomavirus vaccine.

Ferris D, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Reisinger KS, Mehlsen J, Chatterjee A, Iversen OE, Sings HL, Shou Q, Sausser TA, Saah A.

Pediatrics. 2014 Sep;134(3):e657-65. doi: 10.1542/peds.2013-4144. Epub 2014 Aug 18.

26.

Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Løkeland M, Iversen OE, Engeland A, Økland I, Bjørge L.

Acta Obstet Gynecol Scand. 2014 Jul;93(7):647-53. doi: 10.1111/aogs.12398. Epub 2014 May 23.

27.

Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.

Vintermyr OK, Iversen O, Thoresen S, Quint W, Molijn A, de Souza S, Rosillon D, Holl K.

Gynecol Oncol. 2014 May;133(2):159-66. doi: 10.1016/j.ygyno.2014.03.004. Epub 2014 Mar 11.

PMID:
24631451
28.

Psoriasis pathogenesis - Pso p27 is generated from SCCA1 with chymase.

Lysvand H, Hagen L, Klubicka L, Slupphaug G, Iversen OJ.

Biochim Biophys Acta. 2014 May;1842(5):734-8. doi: 10.1016/j.bbadis.2014.02.005. Epub 2014 Feb 18.

29.

[O.E. Iversen replies].

Iversen OE.

Tidsskr Nor Laegeforen. 2013 Oct 1;133(18):1909. doi: 10.4045/tidsskr.13.1192. Norwegian. No abstract available.

30.

[Estrogen and the heart].

Fink Eriksen E, Iversen OE, Syversen U.

Tidsskr Nor Laegeforen. 2013 Sep 3;133(16):1686-7. doi: 10.4045/tidsskr.13.1016. Norwegian. No abstract available.

31.

Legionella pneumophila in Norwegian naval vessels.

Ahlén C, Aas M, Nor A, Wetteland PI, Johansen H, Sørbø T, Sommerfelt-Pettersen JK, Iversen OJ.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1445-8. doi: 10.4045/tidsskr.12.1459. English, Norwegian.

32.

[Should we boycott academic cooperation with China?].

Iversen OE.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1431. doi: 10.4045/tidsskr.13.0798. Norwegian. No abstract available.

33.

[Oral contraceptives, migraine and stroke].

Næss H, Iversen OE.

Tidsskr Nor Laegeforen. 2013 Mar 19;133(6):621-2. doi: 10.4045/tidsskr.12.1524. Norwegian. No abstract available.

34.

[Is it possible to obtain reliable information about the long-term effects of induced abortion?].

Iversen GA, Løkeland M, Fjereide AK, Bjørge L, Iversen OE.

Tidsskr Nor Laegeforen. 2012 Jun 26;132(12-13):1450-2. doi: 10.4045/tidsskr.11.0376. Norwegian.

35.

[Unreasonable thoughts about evidence].

Øian P, Iversen OE, Hordnes K, Backe B.

Tidsskr Nor Laegeforen. 2012 May 29;132(10):1204-5. doi: 10.4045/tidsskr.12.0467. Norwegian. No abstract available.

36.

Concentration of circulating autoantibodies against HSP 60 is lowered through diving when compared to non-diving rats.

Havnes MB, Ahlén C, Brubakk AO, Iversen OJ.

Microb Ecol Health Dis. 2012 Jan 31;23. doi: 10.3402/mehd.v23i0.10677. eCollection 2012.

37.

[More evidence and less politics, please!].

Øian P, Iversen OE, Hordnes K, Backe B.

Tidsskr Nor Laegeforen. 2011 Nov 29;131(23):2346. doi: 10.4045/tidsskr.11.1188. Norwegian. No abstract available.

38.

[Mass examination for gynecological cancer--status and future].

Michelsen TM, Iversen OE.

Tidsskr Nor Laegeforen. 2011 Aug 23;131(16):1550-3. doi: 10.4045/tidsskr.11.0026. Review. Norwegian.

39.

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study.

Naess H, Fromm A, Iversen OE, Thomassen L, Waje-Andreassen U.

Vasc Health Risk Manag. 2011;7:81-4. doi: 10.2147/VHRM.S17219. Epub 2011 Feb 15.

40.

The autoantigen Pso p27: a post-translational modification of SCCA molecules.

Iversen OJ, Lysvand H, Hagen L.

Autoimmunity. 2011 May;44(3):229-34. doi: 10.3109/08916934.2010.530628. Epub 2011 Jan 14.

PMID:
21231892
41.

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.

Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Majewski S, Muñoz N, Sings HL, Harkins K, Rutkowski MA, Haupt RM, Garner EI; FUTURE I and II Study Group.

Int J Cancer. 2011 Mar 15;128(6):1344-53. doi: 10.1002/ijc.25723. Epub 2011 Jan 12.

42.

Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009.

Reid RL, Westhoff C, Mansour D, de Vries C, Verhaeghe J, Boschitsch E, Gompel A, Birkhäuser M, Krepelka P, Dulicek P, Iversen OE, Khamoshina M, Dezman LV, Fruzzetti F, Szarewski A, Wilken-Jensen C, Seidman D, Kaaja R, Shapiro S.

J Fam Plann Reprod Health Care. 2010 Jul;36(3):117-22. doi: 10.1783/147118910791749425. No abstract available.

43.

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.

BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493.

44.

Caesarean section does not prevent cerebral palsy in singleton term breech infants.

Morken NH, Albrechtsen S, Backe B, Iversen OE.

Dev Med Child Neurol. 2010 Jul;52(7):684-5; author reply 685-6. doi: 10.1111/j.1469-8749.2010.03656.x. Epub 2010 Apr 30. No abstract available.

45.

Medical abortion at 63 to 90 days of gestation.

Løkeland M, Iversen OE, Dahle GS, Nappen MH, Ertzeid L, Bjørge L.

Obstet Gynecol. 2010 May;115(5):962-8. doi: 10.1097/AOG.0b013e3181da0c3e.

PMID:
20410769
46.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
47.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Hum Vaccin. 2009 Oct;5(10):696-704. Epub 2009 Oct 1.

PMID:
19855170
48.

Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting.

Wik E, Trovik J, Iversen OE, Engelsen IB, Stefansson IM, Vestrheim LC, Haugland HK, Akslen LA, Salvesen HB.

Am J Obstet Gynecol. 2009 Dec;201(6):603.e1-7. doi: 10.1016/j.ajog.2009.07.029. Epub 2009 Oct 3.

PMID:
19800606
49.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031. Epub 2009 Sep 29.

50.

Expression of the psoriasis-associated antigen, Pso p27, is inhibited by traditional Chinese medicine.

Song P, Lysvand H, Yuhe Y, Liu W, Iversen OJ.

J Ethnopharmacol. 2010 Jan 8;127(1):171-4. doi: 10.1016/j.jep.2009.09.030. Epub 2009 Sep 23.

PMID:
19781613

Supplemental Content

Loading ...
Support Center